These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 34913207)

  • 1. Exuberant lichenoid eruption after Oxford-AstraZeneca COVID-19 vaccine: a singular case.
    Correia C; Fernandes S; Soares-de-Almeida L; Filipe P
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e268-e270. PubMed ID: 34913207
    [No Abstract]   [Full Text] [Related]  

  • 2. Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine.
    Awada B; Abdullah L; Kurban M; Abbas O
    J Cosmet Dermatol; 2022 Mar; 21(3):883-885. PubMed ID: 34997985
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
    Clayton-Chubb D; Schneider D; Freeman E; Kemp W; Roberts SK
    J Hepatol; 2021 Nov; 75(5):1249-1250. PubMed ID: 34171435
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
    Žagar T; Hlača N; Brajac I; Prpić-Massari L; Peternel S; Kaštelan M
    Br J Dermatol; 2022 Mar; 186(3):e110. PubMed ID: 34817862
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.
    Limami Y; Khalki L; Zaid N; Khyatti M; Turk JE; Ammara M; Mtairag EM; Oudghiri M; Naya A; Taberkant M; Zaid Y
    Semin Thromb Hemost; 2022 Feb; 48(1):109-111. PubMed ID: 33971677
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.
    Morlidge C; El-Kateb S; Jeevaratnam P; Thompson B
    Kidney Int; 2021 Aug; 100(2):459. PubMed ID: 34119512
    [No Abstract]   [Full Text] [Related]  

  • 8. Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.
    Nagrani P; Jindal R; Goyal D
    Dermatol Ther; 2021 Sep; 34(5):e15085. PubMed ID: 34350668
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to 'A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine'.
    Martora F; Fabbrocini G; Guerrasio G; Potestio L
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e141-e142. PubMed ID: 36227123
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous lichenoid eruptions following COVID-19 vaccination: A keen observation.
    Arora A; Mohta A; Ghiya BC; Soni P; Jangir VK; Mehta RD
    J Cosmet Dermatol; 2022 Sep; 21(9):3689-3691. PubMed ID: 35778897
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
    Wantavornprasert K; Noppakun N; Klaewsongkram J; Rerknimitr P
    Clin Exp Dermatol; 2022 Feb; 47(2):428-432. PubMed ID: 34482558
    [No Abstract]   [Full Text] [Related]  

  • 14. Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine?
    Cross S; Rho Y; Reddy H; Pepperrell T; Rodgers F; Osborne R; Eni-Olotu A; Banerjee R; Wimmer S; Keestra S
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34937701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination.
    Robichaud J; Côté C; Côté F
    CMAJ; 2021 Aug; 193(34):E1341-E1344. PubMed ID: 34362727
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
    Soltani Hekmat A; Javanmardi K
    Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?
    Kim JE; Lee H; Paik SS; Moon JY; Yoon HJ; Kim SH
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e711-e714. PubMed ID: 34166540
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.
    Moslemi M; Ardalan M; Haramshahi M; Mirzaei H; Sani SK; Dastgir R; Dastgir N
    BMC Infect Dis; 2022 Mar; 22(1):217. PubMed ID: 35241013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.